NCT05380895

Brief Summary

Varicose veins of lower extremities are the most common disease in vascular surgery, and daytime surgery has gradually become the mainstream of varicose veins of lower extremities. Superficial venous thrombosis is one of the common complications of varicose veins of lower limbs. Current consensus is that patients with superficial venous thrombosis should be treated with standardized anticoagulant therapy to prevent their progression to venous thrombotic disease.SVT patients need standardized anticoagulant therapy for a period of time, while DS is current mainstream treatment of VV. Will the existence of SVT affect the safety and efficacy of DS of VV, leading a need of changing the treatment strategy and carrying out anticoagulant treatment for SVT before DS on VV patients? To date, there is no research on this issue. Therefore, we conducted this study to comprehensively evaluate the safety, feasibility, perioperative and long-term efficacy of DS in VV patients complicated with SVT, and systematically compared patients who had VV only.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
699

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 8, 2022

Completed
11 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

June 10, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 10, 2025

Completed
Last Updated

May 19, 2022

Status Verified

May 1, 2022

Enrollment Period

2 years

First QC Date

May 8, 2022

Last Update Submit

May 17, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • postoperative deep venous thrombosis

    deep venous thrombosis after surgery

    Events within one week after surgery

  • saphenous nerve injury

    saphenous nerve injury after surgery

    Events during surgery

  • subcutaneous induration

    subcutaneous induration after surgery

    Events within one week after surgery

Secondary Outcomes (5)

  • varicose veins recurrence

    recurrence within 12 months follow-up after surgery

  • superficial venous thrombosis formation

    Events within 12 months follow-up after surgery

  • deep venous thrombosis

    Events within 12 months follow-up after surgery

  • skin burns

    Events during surgery

  • bleeding requiring intervention

    Events during surgery

Study Arms (2)

SVT group

Varicose vein patients complicated with superficial thrombophlebitis

Non-SVT group

Patients had varicose vein only

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This is a single center retrospective cohort study, which retrospectively analyzed the clinical data of VV patients treated in Sun Yat-sen Memorial Hospital of Sun Yat-sen University from 2015 to 2021. Doppler ultrasound, combined with clinical examination, was used in the diagnosis of SVT.

You may qualify if:

  • VV patients with the CEAP grade of C2-C5;
  • At the age 18 to 75;
  • Treated by day surgery

You may not qualify if:

  • Patient has a history of DVT or is suffering from DVT;
  • Patients with liver and renal failure;
  • Patients in hypercoagulable state;
  • Patients with anticoagulant therapy before operation;
  • Patients with active ulcer;
  • Patient is intolerant to foam sclerotherapy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510120, China

Location

Related Publications (1)

  • Xu J, Xu X, Tian J, Huang M, Xia Z, Luo X, Zheng J, Huang K. Comparison of day surgery between varicose veins with and without superficial venous thrombosis below knee: a propensity score-matched analysis. BMC Cardiovasc Disord. 2023 Aug 3;23(1):387. doi: 10.1186/s12872-023-03398-2.

MeSH Terms

Conditions

Varicose Veins

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Huang Kai, doctor

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 8, 2022

First Posted

May 19, 2022

Study Start

June 10, 2022

Primary Completion

June 10, 2024

Study Completion

June 10, 2025

Last Updated

May 19, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Clinical treatment information that does not design patient privacy

Locations